BioSyent Inc. (OTCMKTS:BIOYF) Sees Significant Growth in Short Interest

BioSyent Inc. (OTCMKTS:BIOYF) was the target of a large growth in short interest in September. As of September 30th, there was short interest totalling 1,900 shares, a growth of 58.3% from the September 15th total of 1,200 shares. Based on an average daily volume of 1,600 shares, the days-to-cover ratio is currently 1.2 days.

BioSyent Stock Performance

Shares of OTCMKTS BIOYF opened at $7.75 on Friday. The firm has a fifty day simple moving average of $7.79 and a two-hundred day simple moving average of $7.14. BioSyent has a 12 month low of $5.65 and a 12 month high of $8.90.

BioSyent Increases Dividend

The firm also recently declared a dividend, which was paid on Sunday, September 15th. Investors of record on Thursday, September 5th were paid a $0.0334 dividend. This represents a dividend yield of 1.72%. This is a positive change from BioSyent’s previous dividend of $0.03. The ex-dividend date of this dividend was Wednesday, September 4th.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.